Holly M. Mortensen, Ph.D.
Affiliations: | Biology | University of Maryland, College Park, College Park, MD |
Area:
human evolution, African genomics, African population historyGoogle:
"Holly Mortensen"Parents
Sign in to add mentor| Sarah A. Tishkoff | grad student | 2008 | University of Maryland | |
| (Genetic variation at the N-acetyltransferase (NAT) genes in global human populations.) | ||||
Collaborators
Sign in to add collaborator| Floyd A. Reed | collaborator | 2006-2009 | University of Maryland (FlyTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Romano JD, Mei L, Senn J, et al. (2023) Exploring genetic influences on adverse outcome pathways using heuristic simulation and graph data science. Computational Toxicology (Amsterdam, Netherlands). 25 |
| Wittwehr C, Clerbaux LA, Edwards S, et al. (2023) Why adverse outcome pathways need to be FAIR. Altex |
| Martens M, Kreidl F, Ehrhart F, et al. (2022) A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma. Frontiers in Oncology. 12: 849640 |
| Mortensen HM, Martens M, Senn J, et al. (2022) The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework. Frontiers in Toxicology. 4: 803983 |
| Boyes WK, Beach B, Chan G, et al. (2022) An EPA database on the effects of engineered nanomaterials-NaKnowBase. Scientific Data. 9: 12 |
| Clerbaux LA, Amigó N, Amorim MJ, et al. (2022) COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop. Altex |
| Mortensen HM, Senn J, Levey T, et al. (2021) The 2021 update of the EPA's adverse outcome pathway database. Scientific Data. 8: 169 |
| Mortensen HM. (2020) Modernization of chemical risk assessment to make use of novel toxicological data. Toxicology and Applied Pharmacology. 394: 114951 |
| Mortensen HM, Chamberlin J, Joubert B, et al. (2018) Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment. Mammalian Genome : Official Journal of the International Mammalian Genome Society |
| Pittman ME, Edwards SW, Ives C, et al. (2018) AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks. Toxicology and Applied Pharmacology |